Supported by the following organizations
This is to certify that Ekaterina Rogatinskaia successfully completed and received a passing grade in 1962USRx: Prescription Drug Regulation, Cost, and Access: Current Controversies in Context a course of study offered by HarvardX, an online learning initiative of Harvard University.
Noted by
Aaron Kesselheim
Associate Professor, Director of the Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Jonathan Darrow
Assistant Professor of Medicine, Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Ameet Sarpatwari
Assistant Professor of Medicine, Assistant Director of the Program On Regulation, Therapeutics, And Law, Brigham and Women's Hospital Harvard University
Jerry Avorn
Professor of Medicine at Harvard Medical School and Emeritus Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics and Co-Director of the Program On Regulation, Therapeutics, And Law Harvard University
-
- Verified Certificate Issued May 21, 2020
- Valid Certificate ID 76c1a5de1ab040b5b2022ea8a0e0c614